Clinical trial

Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes

NCT00160485

Study summary

ClinicalTrials.gov

Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Glyburide Normalized identity: glyburide View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Insulin Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2004-06-01

PhasePHASE4

Conditions

Gestational Diabetesverified · MONDO: gestational diabetes

Interventions

GlyburideDRUG · verified · RxNorm: glyburide

InsulinDRUG

Sponsors & collaborators

Tripler Army Medical Centerlead sponsor

Mapped research locations

HonoluluHawaii, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00160485 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.